12 Although evidence for kidney protection is clearest for semaglutide, benefits on kidney outcomes have also been observed with other GLP-1 receptor agonists, most notably dulaglutide in the REWIND trial
The New England Journal of Medicine, 393 (1), 2636
Vgontzas AN, Zoumakis E, Bixler EO, et al
But these changes may bring about the need for increasing your electrolyte intake, to avoid fatigue, reduced exercise performance, brain fog, or other symptoms
This schedule delivers 4 copper peptide applications per week while accommodating retinol and exfoliation without ingredient conflicts